The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS), alone and in combination with everolimus (E) in patients (pts) with renal cell cancer (RCC).
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
Nizar M. Tannir
Honoraria - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis
Research Funding - Bristol-Myers Squibb; Epizyme; Exelixis; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis; Pfizer
 
James Walter Mier
Research Funding - X4 Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Acceleron Pharma
 
Angela DeMichele
Honoraria - Pfizer
Research Funding - Bayer (Inst); Calithera Biosciences (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Millennium (Inst); Pfizer (Inst); Veridex (Inst); Wyeth (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Melinda L. Telli
Consulting or Advisory Role - Vertex
Research Funding - Abbvie (Inst); Biomarin (Inst); Calithera Biosciences (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); OncoSec (Inst); PharmaMar (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Biomarin; Myriad Genetics
 
Alice C. Fan
No Relationships to Disclose
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)
 
Richard D. Carvajal
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Genentech; Iconic Therapeutics; Janssen; Merck; Novartis; Thomson Reuters
Research Funding - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Celldex; Daiichi Sankyo; Genentech; Immunocore; Incyte; Lilly; Merck; Mirati Therapeutics; Novartis; Regeneron
 
Keith W. Orford
Employment - Calithera Biosciences; GlaxoSmithKline
Stock and Other Ownership Interests - Calithera Biosciences
 
Mark K. Bennett
Employment - Calithera Biosciences
Leadership - Calithera Biosciences
Stock and Other Ownership Interests - Calithera Biosciences
 
Othon Iliopoulos
No Relationships to Disclose
 
Taofeek Kunle Owonikoko
Consulting or Advisory Role - Bayer; Celgene; Genentech/Roche; Novartis
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Celgene (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Genetic predictor of chemotherapy sensitivity (Inst)
 
Manish R. Patel
Honoraria - Gilead Sciences; Medivation; Taiho Pharmaceutical
Speakers' Bureau - Gilead Sciences; Medivation; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Gilead Sciences; Medivation; Taiho Pharmaceutical
 
Rana McKay
Research Funding - Bayer; Pfizer
 
Jeffrey R. Infante
No Relationships to Disclose
 
Martin Henner Voss
Honoraria - Novartis
Consulting or Advisory Role - Calithera Biosciences; Exelixis; GlaxoSmithKline; Natera; Novartis
Research Funding - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Novartis; Takeda
 
James J. Harding
No Relationships to Disclose